Allosteric Modulators for mGlu Receptors

By  

Current Neuropharmacology, Vol. 5, Iss. 3, 2007-09 ,pp. : 187-194

Bentham Science Publishers

Access to resources Recommend Favorite

Metabotropic glutamate receptor 4 (mGlu₄)-positive allosteric modulators for the treatment of Parkinson's disease: historical perspective and review of the patent literature

By Lindsley Craig W   Hopkins Corey R  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 5, 2012-05 ,pp. : 461-481

Informa Healthcare

Access to resources Recommend Favorite

mGluR2 positive allosteric modulators: a patent review (2009 – present)

By Trabanco Andrés A   Cid José María  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 5, 2013-05 ,pp. : 629-647

Informa Healthcare

Access to resources Recommend Favorite

mGluR5 Negative Allosteric Modulators Overview: A Medicinal Chemistry Approach Towards a Series of Novel Therapeutic Agents

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 6, 2011-03 ,pp. : 680-695

Bentham Science Publishers

Access to resources Recommend Favorite

mGluR5 Positive and Negative Allosteric Modulators Differentially Affect Dendritic Spine Density and Morphology in the Prefrontal Cortex

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 4, 2015-05 ,pp. : 476-485

Bentham Science Publishers

Access to resources Recommend Favorite